Weight loss medication for adults with type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called petrelintide to help people with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be an option if you've struggled with weight loss through diet alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) must be 27 or higher.
- You must have type 2 diabetes, with your most recent blood sugar test (HbA1c) between 6.5% and 10%.
- Your diabetes treatment must be stable for at least 90 days—either diet and exercise alone, basal insulin, or certain diabetes pills.
- You must have tried to lose weight through diet before, but it didn't work as well as you hoped.
- You cannot have serious eye problems caused by diabetes (like diabetic retinopathy or macular edema).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
This study tests a new medication called petrelintide to see how well it helps people lose weight and improve their health. It's for adults with overweight or obesity who have struggled to lose weight with diet alone.
This study tests a new combination of two medicines, petrelintide and enicepatide, given as a shot to help with weight loss in people who are overweight or have obesity. The goal is to find the best dose and see if it works well and is safe.
This study tests a new medication called petrelintide to help people with overweight or obesity and heart disease lose weight. It may offer a new way to manage weight and improve heart health.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.